StemCells, Inc. · Palo Alto, CA United States ·(NASDAQ (GM): STEM)
Company Description
View StemCells, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window StemCells hopes a small focus will mean big business. The company discovers cell-based therapies to treat diseases of the central nervous system (CNS), such as cerebral palsy and Alzheimer's disease, as well as spinal cord injury. It is researching stem cell and progenitor cell (cells that have developed from stem cells) therapies to repair neural tissue damaged by disease and injury, and has discovered markers for CNS stem cells and a way to reproduce them for transplant. Its lead therapy candidate may treat Batten disease, a fatal genetic enzyme deficiency. In addition to its CNS research, StemCells is also studying liver cells, hoping to find treatments for diseases such as hepatitis and liver cancer. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key StemCells, Inc. Financials
| Company Type | Public - NASDAQ (GM): STEM Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $0.2 |
| 2008 Employees | 55 |
StemCells, Inc. Executives
17 executives listed for StemCells, Inc.'s Palo Alto, CA location.
| Title | Name & Bio | Contact |
| Chairman | John Schwartz | Network |
| President, CEO, and Director; President, StemCells California | Martin McGlynn | Network |
| SVP Development and Operations | Stewart Craig | Network |
Competition
Competitive Landscape for StemCells, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top StemCells, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!